3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Weight Loss
1
Preleukemia
1
Ovarian Neoplasms
1
Osteochondroma
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Nevus, Epithelioid and Spindle Cell
1
Myelodysplastic Syndromes
1
Malnutrition
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioblastoma
1
Giant Cell Tumors
1
Gastrointestinal Neoplasms
1
Fibrosis
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Merkel Cell
1
Carcinoma, Lobular
1
Carcinoma in Situ
1
Barrett Esophagus
1
Interventions
Melphalan
2
Alemtuzumab
2
fludarabine
1
Stem Cell Transplantation
1
Sertraline
1
Sampling Studies
1
Metformin
1
Clofarabine
1
Bone Marrow Transplantation
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Preleukemia
×
Sampling Studies
×
Clear all
NCT02809222
2021-04-19
PLASMYC
University Hospital, Tours
Phase NA
Completed
138 enrolled